Dr. Reddy's Laboratories
161 hedge funds and large institutions have $1.35B invested in Dr. Reddy's Laboratories in 2021 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 53 increasing their positions, 48 reducing their positions, and 22 closing their positions.
74% more call options, than puts
Call options by funds: $2.35M | Put options by funds: $1.34M
20% more capital invested
Capital invested by funds: $1.13B → $1.35B (+$223M)
14% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 22
10% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 48
1% more funds holding
Funds holding: 160 → 161 (+1)
0.3% more ownership
Funds ownership: 54.99% → 55.29% (+0.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Schroder Investment Management Group
London,
United Kingdom
|
+$45.3M |
| 2 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$9.93M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.95M |
| 4 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$5.04M |
| 5 |
Goldman Sachs
New York
|
+$4.95M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$18.8M |
| 2 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$8.63M |
| 3 |
Mitsubishi UFJ Trust & Banking
Tokyo,
Japan
|
-$8.43M |
| 4 |
Morgan Stanley
New York
|
-$7.1M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$5.95M |
RDY Hedge Fund Activity: Q2 2021 in Review
161 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q2 2021, worth a combined $1.35B — up 20% from $1.13B a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new RDY positions and 22 closed out — a net gain of 3 holders — while 53 added to existing stakes and 48 trimmed.
The largest buyer was Schroder Investment Management Group, adding an estimated $45.3M. The largest seller was Millennium Management, cutting an estimated $18.8M.
- 161 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q2 2021, up from 160 in Q1 2021.
- Funds reported $1.35B of Dr. Reddy's Laboratories stock for Q2 2021, up 20% quarter-over-quarter.
- 25 funds opened new Dr. Reddy's Laboratories positions in Q2 2021 and 22 closed out, a net change of +3 holders.
- The largest Dr. Reddy's Laboratories buyer in Q2 2021 was Schroder Investment Management Group, an estimated $45.3M added.
- The largest Dr. Reddy's Laboratories seller in Q2 2021 was Millennium Management, an estimated $18.8M sold.
Based on aggregated 13F filings for Q2 2021.